Company name changed from Novartis India Limited to Evonile Pharma Limited with effect from October 01, 2026
Company's name changes from Novartis India Limited to Evonile Pharma Limited.
- Effective Date
- October 01, 2026
- Approval
- Special Resolution at the 78th Annual General Meeting held September 24, 2026
- Certificate
- fresh Certificate of Incorporation from the Ministry of Corporate Affairs
- Constitutional Documents
- MoA Name Clause amended; Articles of Association updated with the new name
- Old Name Display Requirement
- old name must be displayed along with the new one for two years
Here is what this update says, in simple terms.
What the company informed the exchange
The company has told BSE that the Ministry of Corporate Affairs, Government of India, issued a fresh Certificate of Incorporation on October 01, 2026 following a change in its name. The name has changed from Novartis India Limited to Evonile Pharma Limited, with effect from October 01, 2026.
How the change was approved
- Shareholders approved the name change by way of a Special Resolution passed at the 78th Annual General Meeting held on September 24, 2026.
- The Ministry of Corporate Affairs, Government of India, then granted its approval, and the fresh Certificate of Incorporation was issued.
What changed in the company's constitutional documents
- Clause I (Name Clause) of the Memorandum of Association has been amended to reflect the new name, Evonile Pharma Limited.
- The Articles of Association stand amended, wherever applicable, to substitute the earlier name with the new name.
What this means
- The company's name on record, in its disclosures and on its website is now Evonile Pharma Limited.
- The certificate states that the change of name does not affect the rights and liabilities of stakeholders.
- The company is required to display its old name along with its new name for a period of two years at all places where the law requires the company to display its name.
- The disclosure and the amended constitutional documents are also available on the company's website.
In short, this is a change of the company's name, supported by shareholder approval and a fresh Certificate of Incorporation from the Ministry of Corporate Affairs, effective October 01, 2026.
Also from Novartis India
CARE A; Stable assigned to Evonile Pharma's long-term bank facilities, CARE A2+ for short-term
7 Oct 2026
Board meeting on October 08, 2026 to consider fund-raise via rights issue of equity shares
5 Oct 2026
Name changed to Evonile Pharma Limited with effect from October 01, 2026; fresh Certificate of Incorporation issued
1 Oct 2026
More numbers
- Period for which the old name must be displayed along with the new nametwo years
- Annual General Meeting at which shareholders approved the name change78th
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.